...
【24h】

Dialysis with icodextrin interferes with measurement of serum alpha-amylase activity.

机译:用艾考糊精透析会干扰血清α-淀粉酶活性的测定。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND:The glucose polymer icodextrin has gained a widespread use in peritoneal dialysis especially in patients with low ultrafiltration and high peritoneal transport properties. In patients using a once-daily exchange with icodextrin, a decreased serum amylase activity has been reported. We explored the potential underlying mechanisms of this effect. METHODS:Using standard chromolytic methods, serum amylase activity was measured in blood samples from 11 patients on icodextrin treatment and from 11 patients on conventional glucose treatment. Samples were additionally supplemented with alpha-amylase and unused icodextrin dialysis fluid. Potential complex formation between icodextrin and alpha-amylase was studied by SDS-gel electrophoresis with protein silver staining and fluorophore-assisted carbohydrate staining with the AMAC (FACE) method, which provides oligosaccharide labelling. Lipase activity was measured in parallel in all samples by two standard methods. RESULTS:Amylase activity was reduced by 90% in serum from patients using icodextrin for the long dwell (15.9+/-10.9 U/l) vs patients using standard glucose (157.1+/-23.7 U/l; P<0.001). Addition of icodextrin to serum samples from patients using conventional glucose solutions induced a dose-dependent decrease in amylase activity. The assay results indicated a substrate competition between ET7-G7PNP and icodextrin. AMAC fluorophore staining of icodextrin and subsequent gel electrophoresis failed to demonstrate complex formation between icodextrin and alpha-amylase. Unlike the amylase findings, icodextrin did not affect lipase activity. CONCLUSIONS:The present findings indicate that icodextrin competitively interacts as a substrate in the amylase assay. In support of this, fluorophore-assisted oligosaccharide electrophoresis on SDS gel failed to reveal the formation of an 'amylase/icodextrin complex'. Lipase measurement should provide an alternative and unconfounded method for diagnosing pancreatitis in icodextrin patients.
机译:背景:葡萄糖聚合物艾考糊精已在腹膜透析中得到广泛应用,尤其是在低超滤和高腹膜转运特性的患者中。在每天一次与艾考糊精交换的患者中,据报道血清淀粉酶活性降低。我们探讨了这种影响的潜在潜在机制。方法:采用标准的色谱分析方法,对11例接受艾考糊精治疗的患者和11例接受常规葡萄糖治疗的患者的血液样本中的血清淀粉酶活性进行了测定。样品还补充有α-淀粉酶和未使用的艾考糊精透析液。通过SDS-凝胶电泳,蛋白银染色和荧光团辅助碳水化合物染色(使用AMAC(FACE)方法)研究了艾考糊精和α-淀粉酶之间潜在的复合物形成,该方法提供了寡糖标记。通过两种标准方法平行测定所有样品中的脂肪酶活性。结果:与使用标准葡萄糖的患者(157.1 +/- 23.7 U / l)相比,长期使用艾考糊精的患者(15.9 +/- 10.9 U / l)血清中的淀粉酶活性降低了90%。使用常规葡萄糖溶液向患者的血清样品中添加艾考糊精会引起淀粉酶活性的剂量依赖性降低。测定结果表明ET7-G7PNP和艾考糊精之间存在底物竞争。艾考糊精的AMAC荧光染色和随后的凝胶电泳未能证明艾考糊精与α-淀粉酶之间形成复合物。与淀粉酶发现不同,艾考糊精不影响脂肪酶的活性。结论:本研究结果表明,艾考糊精在淀粉酶测定中作为底物竞争性相互作用。为此,SDS凝胶上的荧光团辅助寡糖电泳未能显示出“淀粉酶/艾考糊精复合物”的形成。脂肪酶的测定应为艾考糊精患者的胰腺炎诊断提供另一种简便的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号